In conclusion, this study demonstrated the potential protective effect of Metrnl on DKD kidneys by inhibiting the TGF-β1/Smads signaling pathway and reducing the production of fibrotic molecules such as α-SMA. The gene discussed is TGFB1; the disease is diabetic kidney disease.